-+ 0.00%
-+ 0.00%
-+ 0.00%

Kamada Q3 Net Income Jumps 51% to $7.99 Million

PUBT·11/09/2026 12:10:20
Listen to the news
Kamada Q3 Net Income Jumps 51% to $7.99 Million
  • Kamada’s third-quarter 2026 net income jumped 51% year-over-year to $7.99 million.
  • Third-quarter revenues rose 11% year-over-year to $52.03 million, primarily driven by increased KEDRAB, VARIZIG and HEPAGAM sales.
  • Operating cash flow more than doubled year-over-year to $37.64 million in the first nine months of 2026.
  • Plasma collection continued ramping up at Texas facilities to support a three-year supply agreement worth approximately $50 million.
  • Full-year 2026 revenues guidance increased to $205 million–$208 million, with double-digit revenues growth projected for 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kamada Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611090702PRIMZONEFULLFEED9873005) on November 09, 2026, and is solely responsible for the information contained therein.